• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Pancreatic acinar cell carcinoma: A comprehensive review

    2022-11-05 03:45:42LuisFernandoCalimanoRamirezTaherDaoudDheerajReddyGopireddyAjaykumarMoraniRebeccaWatersKazimGumusAlbertRussellKlekersPriyaBhosaleMayurVirarkar
    World Journal of Gastroenterology 2022年40期

    Luis Fernando Calimano-Ramirez,Taher Daoud, Dheeraj Reddy Gopireddy,Ajaykumar C Morani,Rebecca Waters, Kazim Gumus,Albert Russell Klekers,Priya R Bhosale,Mayur K Virarkar

    Abstract Acinar cell carcinoma (ACC) is a rare pancreatic malignancy with distinctive clinical, molecular, and morphological features. The long-term survival of ACC patients is substantially superior to that of pancreatic adenocarcinoma patients.As there are no significant patient series about ACCs, our understanding of this illness is mainly based on case reports and limited patient series. Surgical resection is the treatment of choice for patients with the disease restricted to one organ; however, with recent breakthroughs in precision medicine, medicines targeting the one-of-a-kind molecular profile of ACC are on the horizon. There are no standard treatment protocols available for people in which a total surgical resection to cure the condition is not possible. As a result of shared genetic alterations, ACCs are chemosensitive to agents with activity against pancreatic adenocarcinomas and colorectal carcinomas. The role of neoadjuvant or adjuvant chemoradiotherapy has not been established. This article aims to do a comprehensive literature study and present the most recent information on acinar cell cancer.

    Key Words: Acinar cell carcinoma; Pancreas; Imaging; Immunohistochemical stains;Molecular features; Surgery; Chemotherapy

    INTRODUCTION

    The rising prevalence of abdominal imaging has resulted in an uptick in historically rare pancreatic cancer cases. The exocrine pancreas primarily comprises acinar and ductal cells[1]. Although acinar tissue accounts for most of the pancreatic organ, pancreatic neoplasms that mainly exhibit acinar differentiation are rare. The expression of various pancreatic enzymes, such as chymotrypsin, trypsin, and lipase, leads to acinar differentiation in the exocrine pancreas[1]. Most acinar neoplasms are solid,malignant, and not well-recognized[2]. Acinar cell cystadenoma is the sole benign acinar neoplasm documented; uncommon benign cystic, malignant cystic, and mixed carcinomas also exist.

    Acinar cell carcinoma (ACC) of the pancreas is a rare, malignant tumor composed of cells with morphological resemblance to acinar cells and with evidence of exocrine enzyme synthesis by the neoplastic cells, accounting for 1%-2% of all pancreatic neoplasms[2-4]. ACC of the pancreas is a highgrade malignancy with no apparent site preference; it can occur in any section of the pancreas, but the head is the most common location.

    Currently, there is no definitive course of treatment for ACC; however, vigorous surgical resection with negative margins has been linked to improved long-term survival[5]. Particularly with the use of computerized tomography (CT) and magnetic resonance imaging (MRI), as well as with the confirmation of fine needle aspiration (FNA) biopsies, early recognition and diagnosis are of particular relevance. Knowledge of these lesions' morphologic and immunohistochemical characteristics is also essential for a precise clinical diagnosis. In addition, extensive molecular analyses of acinar neoplasms have identified genomic alterations that may be amenable to specific therapies, thereby increasing the likelihood of widespread clinical molecular testing of these tumors.

    This article aims to do a comprehensive literature study and present the most recent information on acinar cell cancer.

    EPIDEMIOLOGY

    ACC of the pancreas accounts for 1%-2% of all adult exocrine pancreatic neoplasms and 15% of pediatric neoplasms. ACC occurs most frequently in white males and is usually bimodal in age, with peaks in childhood at 8-15 years of age and adulthood with a peak incidence at 60 and is rare between the ages of 20 and 40. ACC has a 3.6 male-to-female ratio. No known racial relationships exist[1,6,7].

    CLINICAL FEATURES

    Most ACC s exhibit vague symptoms, which include weight loss (45%), abdominal pain (60%), back pain (50%), nausea and vomiting (20%), melena (12%), weakness, anorexia, and diarrhea (8%) are typical non-specific symptoms of ACC[8,9]. In distinction to ductal adenocarcinoma, ACC infrequently obstructs the bile duct and causes jaundice only in 12% of patients. ACC causes a mass effect and displaces those organs but does not infiltrate[10].

    Some patients experience paraneoplastic disease known as "Schmid's Triad" or lipase hypersecretion syndrome due to increased lipase levels reaching over 10000 U/dL[11,12]. Elevated lipase may be the first sign of ACC. Patients may present with multiple nodular foci of subcutaneous fat necrosis,polyarthralgia may occur due to fat necrosis in the cancellous bone, and may have peripheral blood eosinophilia[13,14]. On imaging, fat necrosis within the bone can appear as a focal area of sclerosis.Paraneoplastic syndrome may occur following tumor recurrence. Most patients have hepatic metastases at presentation; however, some may present with only a bulky pancreatic mass. The serum lipase levels may normalize after surgical resection of the tumor, and patients may have symptomatic relief. Lipase may be used as a tumor marker in these patients. Alpha-fetoprotein (AFP) blood levels can be elevated in young patients[15].

    MACROSCOPY (GROSS FEATURES)

    On FNA, an abundance of cells with fluctuating degrees of acinar differentiation but no endocrine or ductal cells are seen. The aspirates consist primarily of cohesive fragments creating acini, cellular cords,or solid nests of neoplastic epithelium, composed of clusters of uniform cells with smoothly contoured,eccentric nuclei containing one or two prominent nuclei nucleoli[16,17].

    ACCs can occur in any region of the pancreas and, on average, are 10 to 11 cm in size at the time of diagnosis[18-20]. The tumors are well circumscribed and have a soft, fleshy, tan to red appearance[2].They occasionally exhibit lobulated appearances, necrosis, and cystic degeneration[20]. On occasion, the neoplasm is found attached to the surface of the pancreas. Involvement of the duct system by ACCs can sometimes be observed grossly as polypoid or fingerlike projections extending from the primary tumor mass toward the duct[21].

    PATHOLOGY

    ACCs are cellular neoplasms with minimal stroma on microscopic examination. Multiple architectural patterns, including acinar (Figure 1A), solid (Figure 1B), glandular (Figure 1C), and trabecular(Figure 1D), can be observed. Solid and acinar patterns are the most prevalent. The acinar pattern is characterized by structures resembling normal acini, with small lumina and cells arranged in a monolayer with basally located nuclei. Large sheets of cells depict the solid pattern without lumina.Acinar structures with the dilated lumen characterize the less common granular pattern. The trabecular pattern, which resembles the architecture of well-differentiated neuroendocrine tumors, consists of more pronounced palisading with thinner, interlacing ribbons of cells. Multiple architectural patterns are visible within a single tumor.

    IMMUNOHISTOCHEMISTRY

    The immunohistochemical labeling of enzyme production from pancreatic cells aids in confirming the diagnosis of ACC (Table 1). There are commercially available antibodies for chymotrypsin, trypsin,lipase, and amylase, with the first three being the most frequently used in clinical settings (Figure 1E).These enzymes exhibit varying degrees of specificity and sensitivity. In approximately 95% of cases,trypsin and chymotrypsin reactivity can be demonstrated, and this combination is reportedly the most sensitive for diagnosing ACC[10,22].

    ACC is also positive for CK8 and CK18, and as a result, they will label for AE1/AE3 and CAM5.2.CK7 (Figure 1F) and CK19, which are usually expressed in ductal adenocarcinomas, are generally missing in ACC but may be expressed in a subgroup of ACCs[15,23]. Focal labeling for chromogranin and synaptophysin is observed in a substantial proportion of ACCs, displaying the need to assess with further clear-cut acinar markers, especially in small samples, to avoid misidentifying an ACC as a neuroendocrine tumor or mixed acinar-neuroendocrine differentiation[10,24,25]. Recent research on histological and cytological samples has proven that the monoclonal antibody directed against the COOH-terminal region of the BCL10 protein, which identifies the COOH-terminal portion of CEL, is a highly specific and sensitive approach for detecting ACCs[26,27].

    MOLECULAR FEATURES

    The genetic alterations driving ACC have been thoroughly characterized and sequenced. The outcomes of these studies have emphasized the diversity of modified genes and pathways among various tumors,as well as the marked genomic instability in a subset of instances, including at the base pairs and chromosomes level. Several studies analyzed ACC for mutations in gene changed in pancreatic ductal adenocarcinoma (PDAC), the most prevalent subtype of pancreatic cancer, before the wide availability of whole genome and exome. Several of these studies reported uncommon mutations inTP53,KRAS,andSMAD4, in addition to the unusual loss of SMAD4 expression in acinar neoplasms, while others reported no modifications in these genes[28-33]. In these studies, the most prevalent ACC mutationsaffected WNT signalings, such as mutations in APC that rendered inactive and mutations in CTNNB1 that rendered it active; these alterations were found in roughly 20% of ACCs[30]. Recent sequencing studies of the entire exome have highlighted the diversity of mutated genes in the ACC[34,35]. Several other studies have shown substantial chromosomal gains and losses in ACCs and altered regions in various carcinomas; nevertheless, the target genes (if any) in these regions have not been detected[29,30,36,37].

    Table 1 Immunohistochemical profile from the differential diagnosis

    Figure 1 Histopathological patterns. A: Acinar cell carcinoma with the predominant acinar pattern. The acinar pattern is characterized by structures resembling normal acini, with small lumina and cells arranged in a monolayer with basally located nuclei; B: Acinar cell carcinoma with the predominant glandular pattern. Acinar structures with dilated lumina characterize the glandular pattern; C: Acinar cell carcinoma with the predominant trabecular pattern. The trabecular pattern is characterized by ribbons of cells resembling those of pancreatic neuroendocrine tumors; D: Acinar cell carcinoma with a predominant solid pattern. Large sheets of cells characterize the solid pattern without lumina; E: Acinar cell carcinoma, immunohistochemical staining for trypsin; F: Acinar cell carcinoma, immunohistochemical staining for cytokeratin 7.

    Multiple potentially targetable genetic alterations in pancreatic ACC have been identified. A subset of cases exhibits genomic instability due to mutations in genes involved in DNA repairs, such asATM,BRCA1,BRCA2,PALB2, andMSH2[34,35]. According to various studies, microsatellite instability has been documented in fluctuating proportions of ACC, ranging from 7% to 14%[30,35,38]. Also, platinum agents and PARP inhibitors treat tumors with mutations in BRCA pathway genes[39,40]. Even though it has not yet been proven in major clinical trials, preliminary findings indicate that tumors with BRAF fusions react to MEK inhibitors, providing ACC with targeted therapy[41-43]. In a subgroup of ACCs,MYC abnormalities, including chromosome 8 polysomy and gene amplification, have been identified recently[44].

    Table 2 Summary of pertinent differential diagnostic features

    DIAGNOSIS

    Laboratory analysis

    Besides an increase in serum lipase levels associated with the syndrome of lipase hypersecretion, serum tumor markers are not consistently elevated in ACC. Even in the absence of lipase hypersecretion syndrome, lipase might be high. There have been numerous AFP increases, especially in younger patients[2]. Typically, Serum tumor markers such as carbohydrate antigen 19-9, alpha-fetoprotein, and carcinoembryonic antigen are expressed.

    Radiological features (imaging)

    In recent years, the incidence of uncommon pancreatic cancers has grown, likely due to the increased use of cross-sectional imaging[45]. In most instances, pancreatic cancers are incidentally found by CT.MRI is often used as a secondary test for further characterization. ACC of the pancreas is a well-defined,primarily oval or round exophytic mass in cross-sectional imaging[46,47]. Rarely have cystic variations been described. Typically, it manifests as a dense, largely solid tumor devoid of noticeable cystic alterations[46,48]. One-third of patients may exhibit calcifications, and the majority of the tumor increases constantly, but less so than the adjacent pancreatic parenchyma[49]. The tumor displays heterogeneous enhancement after intravenous infusion of contrast material[46]. Other studies also concluded that when confronted with a large mass with an ovoid shape, exophytic, well-circumscribed arising from the pancreas, with slight and persistent enhancement after contrast administration, and without appreciable biliary or pancreatic dilation, the diagnosis of ACC should be considered[18,47,50].Another study stated that MRI is better than CT for identifying tumor margination, intratumoral bleeding, tissue invasion, and ductal dilation[51]. On the other hand, CT is more sensitive to detecting central calcification and is commonly utilized due to its accessibility and quickness[50,51]. CT and MRI accurately depict most ACC imaging characteristics, and the two modalities correlate well[51].

    Differential diagnosis

    Pancreatic endocrine neoplasms that are well-differentiated, solid pseudopapillary neoplasms (SPNs),mixed acinar neoplasms, pancreatoblastoma (PBL), and PDACs should be included in the differential diagnosis (Table 2). Well-differentiated endocrine neoplasm, also commonly known as pancreatic neuroendocrine tumors (PanNET), is the entity most widely confused and misdiagnosed[2]. Both neoplasms typically contain a high number of cells and little amount of stroma, are capable of forming cell sheets and can consist of medium-sized, spherical, monomorphic cells with a microglandular or solid pattern of growth[2]. In addition, the red cytoplasmic zymogen and neurosecretory granules from ACC and PanNETs, respectively, are similar with appropriate differentiation. PanNETs are associated with a more favorable prognosis, making differentiation crucial. ACCs are distinguished from PanNETs by their primary acinar development, cytoplasmic granulation, basally oriented nuclei, and individual conspicuous nucleoli. However, hyalinized stroma, plasmacytoid cell appearance, and a "salt and pepper" chromatin pattern are indicative of PanNET[6]. Immunohistochemistry is advantageous, but it must be utilized with care. Using general neuroendocrine markers such as synaptophysin and chromogranin A alone may be unsafe because several ACCs contain neuroendocrine cells, which are particularly abundant in 30% of cases, as stated before[10,24]. Therefore, the demonstration of acinar cell products is mandatory if an ACC is suspected.

    SPNs present as massive, dense pancreatic masses that are clinically identical to ACC; however, SPNs virtually entirely affect women of young age[52]. Cytological smears are characterized by delicately branched vasculature with lightly adherent cells generating pseudopapillary structures, a homogenous population of microscopic cells with cuboidal formation, and a unique hyaline myxoid matrix[52].Additionally, cytoplasmic hyaline globules are occasionally visible. Moreover, the SPNs nuclei are often normochromic, with numerous indentations, and lack the conspicuous nucleoli found in acinar cells[53]. Typically, SPNs exhibit nuclear immunoreactivity for β-catenin and high expression of CD10,which are also detectable in roughly 10% and 60% of ACCs, respectively. As a result, these two markers must be utilized in conjunction with markers specific to acinar cells, such as trypsin and BCL10[53-55].

    PBL is another entity with stroma-poor acinar differentiation that must be evaluated in the differential diagnosis. Similar to ACCs, upon the appearance, PBLs are typically large, with an average size of 10 cm ranging from 1.5 to 20 cm[56]. This uncommon tumor shares nearly all of the cytologic and clinical characteristics of ACC, notably in the population of younger age, where it is frequently observed[2,57]. Cytologically, the neoplasms may be indistinguishable because they both display a predominant acinar-cell differentiation[2]. Heterologous components and squamous nests, such as osseous and cartilage development, characterize PBL[2]. In addition to immunochemistry and clinicopathologic data,the heterogeneous cytologic elements of the types of the tumor-cell present, including a combination of squamoid, mesenchymal, and glandular cells, are a general clue to diagnosing PBL[58]. Histologically,the presence of squamoid nests in PBL is the distinguishing characteristic of the two entities.

    ACCs typically lack the characteristic cytomorphologic features of PDACs, allowing these two tumors to be distinguished easily. PDACs typically exhibit "drunk honeycomb" and "tombstone cells"arrangements alongside nuclear heterogeneity and nuclear silhouette abnormalities[59]. This is in contrast to the relatively homogeneous polygonal cells of ACCs, which are arranged in threedimensional arrays and tissue fragments[1]. ACCs lack the large desmoplastic stroma that describes PDACs and display an overall solid and acinar architecture, whereas PDACs feature a prominent desmoplastic stroma[10,59,60].

    STAGING FOR ACINAR PANCREATIC CARCINOMA

    The staging system for acinar pancreatic cancer is undergoing continuous development. Clinical staging is determined by resectability, which is heavily impacted by surgical expertise. The agreed guidelines for the resectability of surgical procedures continue to be refined (e.g., National Comprehensive Cancer Network, MD Anderson Cancer Center, American Hepato-Pancreato-Biliary Association, and International Hepato-Pancreato-Biliary Association). Traditionally, they are categorized as resectable,borderline resectable, locally progressed, and metastatic. To begin with, resectable tumors lack vascular involvement. Next, the borderline resectable tumors involve vascular, local structures, or other signs indicating a high risk of R1 resection. Local invasions (particularly vascular involvement) prevent surgical intervention for locally progressed malignancies. Lastly, metastatic cancer has spread to other organs beyond the main pancreatic tumor. The American Joint Committee on Cancer (AJCC) has classified staging by TNM (tumor, node, metastasis) classification using the consensus guidelines for resectability (Table 3 and Figure 2)[61]. Imaging cases with different AJCC TNM staging were added in chronological order (Figures 3 - 7) to appreciate the differences in changes.

    PROGNOSIS, FACTORS OF PREDICTION, SPREAD, AND METASTASES

    ACCs are exceptionally malignant neoplasms; relatively 50% of patients have metastasis during diagnosis[62]. Initial studies indicate that the prognosis for ACCs is better than that for ductal carcinomas but worse than that for PanNETs[5,63,64]. Previous research using population-based cancer databases and epidemiological methods indicated that individuals diagnosed with ACCs have a median overall survival time of roughly 47 mo for patients with localized disease and 14 mo for patients with metastatic disease, with a 5-year survival rate ranging from 36.2% to 72.8% for resected cancers[5,64,65].A recent study shows that ACC has a better prognosis than adenocarcinoma. They found that the prognosis was deteriorating with a decrease of 25% in a 5-year survival rate to previously reported rates[66]. However, data from a few studies published and anecdotal reports hint that some patients with ACCs have a greater survival rate than expected; unfortunately, no parameters are available to identify this group of patients[67,68].

    Figure 2 American Joint Committee on Cancer 8th Edition cancer staging for exocrine pancreatic tumor such as pancreatic acinar cell carcinoma. A: Stage 0 (TNM: Tis, N0, M0). Tis = Carcinoma in situ. N0 = No regional lymph node metastases. M0 = No distant metastasis; B: Stage IA (TNM: T1,N0, M0). T1 = Tumor ≤ 2 cm in greatest dimension. N0 = No regional lymph node metastases. M0 = No distant metastasis; C: Stage IB (TNM: T2, N0, M0). T2 =Tumor > 2 cm and ≤ 4 cm in greatest dimension. N0 = No regional lymph node metastases. M0 = No distant metastasis; D: Stage IIA (TNM: T3, N0, M0). T3 = Tumor> 4 cm in greatest dimension. N0 = No regional lymph node metastases. M0 = No distant metastasis; E: Stage IIB (TNM: T 1/2/3, N1, M0). T 1/2/3 = Tumor ≤ 2 cm >4 cm in greatest dimension. N1 = Metastasis in one to three regional lymph nodes. M0 = No distant metastasis; F: Stage III (TNM: T 1/2/3, N2, M0 or T4, Any N, M0).T 1/2/3 = Tumor ≤ 2 cm > 4 cm in greatest dimension. N2 = Metastasis in four or more regional lymph nodes. T4 = Tumor involves celiac axis, superior mesenteric artery, and common hepatic artery, regardless of size; G: Stage IV (TNM: Any T, Any N, M1). M1 = Distant metastasis. T = Primary tumor; N = Regional lymph node;M = Distant metastasis.

    Figure 3 Stage IA (T1, N0, M0). A 77-year-old male patient with acinar cell carcinoma. Axial post-contrast portal-venous phase computed tomography image shows a solid mass (short arrows) measuring 1.8 cm × 1.6 cm and involving the region of the pancreatic head/body. Incidental findings are calcifications seen throughout the pancreas (likely related to changes in chronic pancreatitis) and mild dilatation of the biliary tree with pneumobilia (long arrow).

    Rarely do patients with ACC are diagnose with lung, cervical lymph nodes, and ovary metastases.Metastatic illness is typically detected in regional lymph nodes and the liver[69]. Patients presenting as their first disease symptom with distant metastases are infrequent. It has been proposed that ACCs in patients younger than 20 may be less aggressive than in adults[10]. The most significant prognostic indicator is the tumor stage, with patients without lymph nodes or distant metastases having a better prognosis[5,70]. In addition, a poor prognosis is also associated with being male, being over 60, and having a tumor larger than 10 cm[5].

    TREATMENT

    Current, surgical, radiotherapeutic, and chemotherapeutic treatments used for PDAC are typically used to treat ACC (Table 4). Surgery is regarded as the optimal treatment modality for ACCs that areregionally circumscribed and resectable. Holenet al[8]found that median survival for surgically resected cases was 36 mo, compared to 14 mo for those without surgical resection[8]. Another systematic research by Glazeret al[71]indicated that the total median survival rate for patients with ACC who had resection was approximately 47 mo[71]. More aggressive therapeutic regimens must be sought when surgery is unavailable for locally advanced and metastatic diseases.

    Table 3 American Joint Committee on Cancer 8th Edition cancer staging for exocrine pancreatic tumor such as pancreatic acinar cell carcinoma

    large blood vessels2 Any N NX = Regional lymph nodes cannot be assessed N0 = No regional lymph node metastases N1 = Metastasis in one to three regional lymph nodes N2 = Metastasis in four or more regional lymph nodes M0 No distant metastasis IV Any T TX = Primary tumor cannot be assessed T0 = No evidence of primary tumor Tis = Carcinoma in situ1 T1 = Tumor is ≤ 2 cm in any direction T1a = Tumor is ≤ 0.5 cm in any direction T1b = Tumor is > 0.5 cm and < 1 cm in any direction T1c = Tumor is 1-2 cm in any direction T2 = Tumor is > 2 cm and ≤ 4 cm in any direction T3 = Tumor is > 4 cm in any direction T4 = Regardless of tumor size, the cancer has grown outside the pancreas, into the nearby large blood vessels2 Any N NX = Regional lymph nodes cannot be assessed N0 = No regional lymph node metastases N1 = Metastasis in one to three regional lymph nodes N2 = Metastasis in four or more regional lymph nodes M1 Distant metastasis 1Included in this category are high-grade pancreatic intraepithelial neoplasia, intraductal papillary mucinous neoplasm with high-grade dysplasia,intraductal tubulopapillary neoplasm with high-grade dysplasia, and mucinous cystic neoplasm with high-grade dysplasia.2Celiac axis, superior mesenteric artery, and/or common hepatic artery are involved.T: Primary tumor; N: Regional lymph node; M: Distant metastasis.

    Table 4 Acinar cell carcinoma treatment options

    Figure 4 Stage IB (T2, N0, M0). An 89-year-old male patient with acinar cell carcinoma. Axial post-contrast computed tomography arterial phase image shows a large mass in the body of the pancreas (arrow) measuring 3.3 cm × 3 cm. No regional adenopathy is identified.

    Figure 5 Stage IIA (T3, N0, M0). A 66-year-old patient with acinar cell carcinoma. Axial post-contrast computed tomography image in the arterial phase shows a solid lobulated mass measuring 6.5 cm × 5.4 cm arising from the tail of the pancreas (arrow). The mass is heterogeneous in density with areas of low-density and solid-enhancing areas. No regional or distant lymphadenopathy was detected.

    Due to the rareness of ACC and the absence of sufficient randomized trials comparing different treatment approaches, the role of adjuvant therapy remains debatable. Table 5 enlists characteristics of studies on various regimes used for treating ACC. In a study at Memorial Sloan-Kettering Cancer Center, systemic chemotherapy for ACC was determined to be ineffective[8]. Following surgical resection, there are no clear treatment guidelines, and most adjuvant therapies are individualized with variable response rates. Lack of prospective data to create therapy guidelines and genetic variation in theAPCgene/β-catenin pathway observed in pancreatic acinar cells, ACC patients are frequently treated with chemotherapeutic agents known to be active against PDAC or colorectal cancer[72]. Most study participants received combination chemotherapy protocols based on gemcitabine or fluoropyrimidine[11,73]. If the ACC cannot be resected, the patient should undergo neoadjuvant or palliative 5-FU chemotherapy[70,74]. Combination fluoropyrimidine-based chemotherapies have increased disease control rates[8,11,73,75-77]. Glazeret al[71]systematic review showed that patients with a high-performance status typically receive folinic acid/fluorouracil/oxaliplatin or folinic acid/fluorouracil/irinotecan. In contrast, patients with a lower performance status typically receive gemcitabine/protein-bound paclitaxel[71].

    Conventional fractionation and hypofractionated stereotactic body radiotherapy are used to "downstage" or convert a borderline resectable tumor to one that is resectable[73]. Patients who could potentially benefit from resection can be identified through the absence of ACC development following neoadjuvant radiotherapy. Several studies reported a "major response" rate from 25% to 35% of these individuals[8,11].

    Figure 6 Stage IIB (T3, N1, M0). A 61-year-old patient with acinar cell carcinoma. A: Axial post-contrast computed tomography (CT) image in the portovenous phase shows an infiltrative mass arising from the pancreatic body and tail (arrow); B: axial post-contrast CT images in the portovenous phase shows an enlarged mesenteric lymph node (arrow) measuring 2.6 cm × 1.2 cm; C: Axial positron emission tomography/CT image in the portovenous phase shows hypermetabolic pancreatic body and tail mass (arrow); D: Axial post-contrast CT images in the portovenous phase shows hypermetabolic enlarged mesenteric lymph node (arrow).Pathology of the mass revealed Acinar cell carcinoma with a metastatic mesenteric lymph node.

    Figure 7 Stage IV. A 64-year-old patient with acinar cell carcinoma. A: Axial post-contrast image port venous phase shows a pancreatic head mass measuring about 3.2 cm × 2.8 cm (arrow); B: Axial post-contrast image port venous phase shows multiple bilobar variable-sized hepatic metastatic lesions (arrows). An incidental finding is an area of splenic infarction (asterisk in image A).

    CONCLUSION

    Pancreatic acinar neoplasms are a molecularly and morphologically heterogeneous group of diseases far less prevalent than ductal neoplasms. Due to its low surgical resectability, high rate of recurrence, and high frequency of metastases at diagnosis, pancreatic ACC has been regarded as cancer with a poor prognosis. At least a subset of the neoplastic cells exhibits acinar differentiation, as defined morphologically (granular cytoplasm, single prominent nucleoli) or immunohistochemically. The molecular system underlying the advancement of ACCs has been elucidated, revealing potentially targetable mutations that offer optimism for developing additional curative options. ACC usually appears as a bulky mass that does not obstruct the pancreatic or bile duct and does not cause jaundice. Elevated lipase levels, subcutaneous nodules, and the presence of bone infarct should help clinch a diagnosis of ACC. Also, these tumors have large lymph nodes at presentation. In the future, molecular diagnostics to detect lesions susceptible to targeted therapy will likely play an important role in patient care.

    Table 5 Characteristics of studies on various acinar cell carcinoma treatment regimes

    ACC: Acinar cell carcinoma; PDAC: Pancreatic ductal adenocarcinoma; RT: Radiotherapy; 5-FU: 5-fluorouracil; SOX: S1 + Oxaliplatin; AG: Albumin-bound paclitaxel + gemcitabine; FOLFIRNOX: 5-FU + oxaliplatin + leucovorin + irinotecan.

    ACKNOWLEDGEMENTS

    We thank Kelly Kage for the beautiful illustrations.

    FOOTNOTES

    Author contributions:All authors equally contributed to this paper with the conception and design of the study,literature review and analysis, drafting, critical revision, editing, and approval of the final version.

    Conflict-of-interest statement:All the authors report no relevant conflicts of interest for this article.

    Open-Access:This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BYNC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is noncommercial. See: https://creativecommons.org/Licenses/by-nc/4.0/

    Country/Territory of origin:United States

    ORCID number:Luis Fernando Calimano-Ramirez 0000-0003-2599-3179; Taher Daoud 0000-0001-9161-1314; Dheeraj Reddy Gopireddy 0000-0001-8441-7804; Ajaykumar C Morani 0000-0002-2936-0291; Rebecca Waters 0000-0002-8163-7497; Kazim Gumus 0000-0002-1450-6868; Albert Russell Klekers 0000-0003-1202-7369; Priya R Bhosale 0000-0003-4014-4941; Mayur K Virarkar 0000-0002-5825-3102.

    S-Editor:Fan JR

    L-Editor:A

    P-Editor:Fan JR

    看非洲黑人一级黄片| 日本午夜av视频| 国产av精品麻豆| 免费人妻精品一区二区三区视频| 美女脱内裤让男人舔精品视频| av女优亚洲男人天堂| 欧美人与性动交α欧美精品济南到 | av视频免费观看在线观看| 久久婷婷青草| 尾随美女入室| 久久久久精品人妻al黑| 亚洲中文av在线| 女人久久www免费人成看片| 亚洲国产精品999| 欧美日本中文国产一区发布| 免费看光身美女| 欧美最新免费一区二区三区| 寂寞人妻少妇视频99o| 日本av免费视频播放| 男女下面插进去视频免费观看 | 国产精品熟女久久久久浪| 人妻系列 视频| 巨乳人妻的诱惑在线观看| 亚洲,欧美精品.| 欧美xxⅹ黑人| 日韩不卡一区二区三区视频在线| 亚洲一码二码三码区别大吗| 久久精品久久久久久噜噜老黄| 亚洲国产精品专区欧美| 综合色丁香网| 国产 精品1| 九九爱精品视频在线观看| 丰满饥渴人妻一区二区三| 亚洲三级黄色毛片| 国产在线视频一区二区| 亚洲精品乱码久久久久久按摩| 亚洲欧洲国产日韩| 欧美性感艳星| 欧美 亚洲 国产 日韩一| 99久国产av精品国产电影| 最近手机中文字幕大全| 欧美日韩av久久| 国产欧美日韩一区二区三区在线| 国产成人精品一,二区| 丝袜在线中文字幕| 免费黄网站久久成人精品| 中文乱码字字幕精品一区二区三区| a 毛片基地| 亚洲av免费高清在线观看| 国产精品99久久99久久久不卡 | 日韩精品有码人妻一区| 亚洲av.av天堂| 97在线视频观看| 日韩成人av中文字幕在线观看| 亚洲成人手机| 51国产日韩欧美| 纯流量卡能插随身wifi吗| 国产日韩欧美在线精品| 亚洲精品一二三| 女人久久www免费人成看片| 91午夜精品亚洲一区二区三区| 最新中文字幕久久久久| 国产国语露脸激情在线看| 男女边吃奶边做爰视频| 成人免费观看视频高清| 色网站视频免费| 国产 一区精品| 搡女人真爽免费视频火全软件| 免费不卡的大黄色大毛片视频在线观看| 久久热在线av| 亚洲av免费高清在线观看| 日韩一区二区三区影片| 性色av一级| 91成人精品电影| 午夜老司机福利剧场| 99热这里只有是精品在线观看| 九九爱精品视频在线观看| 精品国产一区二区三区四区第35| 亚洲三级黄色毛片| 成人黄色视频免费在线看| 亚洲精品乱久久久久久| 成人国语在线视频| 亚洲欧洲精品一区二区精品久久久 | 国产成人aa在线观看| 欧美国产精品va在线观看不卡| 热99国产精品久久久久久7| 亚洲精品中文字幕在线视频| av在线app专区| 亚洲少妇的诱惑av| 国产一区有黄有色的免费视频| 国产熟女午夜一区二区三区| 国产精品麻豆人妻色哟哟久久| 亚洲国产看品久久| 18+在线观看网站| 国产日韩欧美亚洲二区| 久久鲁丝午夜福利片| 亚洲国产日韩一区二区| 五月开心婷婷网| 一级毛片我不卡| 国产精品偷伦视频观看了| 另类亚洲欧美激情| 国产欧美亚洲国产| 国产熟女欧美一区二区| 国产福利在线免费观看视频| 欧美亚洲 丝袜 人妻 在线| 婷婷色综合大香蕉| 日本猛色少妇xxxxx猛交久久| 国精品久久久久久国模美| 一二三四在线观看免费中文在 | 国产av一区二区精品久久| 欧美变态另类bdsm刘玥| 欧美激情国产日韩精品一区| 亚洲人成网站在线观看播放| 欧美日本中文国产一区发布| 国产av精品麻豆| av播播在线观看一区| 中国三级夫妇交换| 国产视频首页在线观看| 国产1区2区3区精品| 亚洲精品第二区| 丁香六月天网| 免费看光身美女| 亚洲一区二区三区欧美精品| 国产男人的电影天堂91| av卡一久久| 国产无遮挡羞羞视频在线观看| 久久久精品免费免费高清| 男女免费视频国产| av片东京热男人的天堂| 有码 亚洲区| 亚洲av免费高清在线观看| 狠狠精品人妻久久久久久综合| 国产xxxxx性猛交| 免费av不卡在线播放| 日本午夜av视频| 亚洲国产精品一区三区| 中文乱码字字幕精品一区二区三区| 久久精品国产亚洲av天美| 女性生殖器流出的白浆| 午夜福利,免费看| 欧美精品一区二区免费开放| 国语对白做爰xxxⅹ性视频网站| 夜夜爽夜夜爽视频| 91aial.com中文字幕在线观看| 一二三四中文在线观看免费高清| 成年女人在线观看亚洲视频| 日韩伦理黄色片| 人妻人人澡人人爽人人| 欧美激情国产日韩精品一区| 日韩中文字幕视频在线看片| 国产亚洲一区二区精品| 日本免费在线观看一区| 日韩成人av中文字幕在线观看| 国产乱人偷精品视频| 大话2 男鬼变身卡| 免费大片18禁| 日本欧美视频一区| 国产精品无大码| 卡戴珊不雅视频在线播放| 婷婷成人精品国产| videosex国产| 久久久久视频综合| 免费看av在线观看网站| 寂寞人妻少妇视频99o| 久久午夜综合久久蜜桃| av在线老鸭窝| 亚洲精品视频女| 一二三四中文在线观看免费高清| av视频免费观看在线观看| 婷婷色综合大香蕉| 亚洲国产精品成人久久小说| av有码第一页| 制服人妻中文乱码| 极品少妇高潮喷水抽搐| 男人操女人黄网站| a 毛片基地| 欧美日本中文国产一区发布| 多毛熟女@视频| 国产精品蜜桃在线观看| 中文天堂在线官网| 咕卡用的链子| 在线精品无人区一区二区三| 2018国产大陆天天弄谢| 九九爱精品视频在线观看| 男女下面插进去视频免费观看 | 欧美日本中文国产一区发布| 丰满乱子伦码专区| 国产亚洲av片在线观看秒播厂| a级毛片在线看网站| 亚洲精品久久午夜乱码| 天天影视国产精品| 久久精品国产亚洲av天美| 赤兔流量卡办理| 亚洲第一区二区三区不卡| 精品国产乱码久久久久久小说| 免费久久久久久久精品成人欧美视频 | 国产黄色视频一区二区在线观看| 极品少妇高潮喷水抽搐| 九九在线视频观看精品| 亚洲成国产人片在线观看| 水蜜桃什么品种好| 人妻一区二区av| 最新中文字幕久久久久| 丰满少妇做爰视频| 国产又爽黄色视频| 精品福利永久在线观看| 青春草亚洲视频在线观看| 99热6这里只有精品| 国产精品不卡视频一区二区| 成人国产麻豆网| 丝袜美足系列| 国产日韩欧美亚洲二区| 免费女性裸体啪啪无遮挡网站| 亚洲国产av新网站| 国产精品免费大片| 色婷婷久久久亚洲欧美| 最近的中文字幕免费完整| 性色av一级| 国产成人精品婷婷| 亚洲欧美日韩另类电影网站| 热99久久久久精品小说推荐| 永久网站在线| 狂野欧美激情性xxxx在线观看| 久久人人爽人人片av| 亚洲成av片中文字幕在线观看 | 曰老女人黄片| 亚洲欧美日韩另类电影网站| 丝瓜视频免费看黄片| 免费人成在线观看视频色| 永久免费av网站大全| 国产一区二区三区av在线| 观看美女的网站| 天天躁夜夜躁狠狠躁躁| 99re6热这里在线精品视频| 国产熟女午夜一区二区三区| www.熟女人妻精品国产 | 在线观看三级黄色| 国产精品国产三级国产专区5o| h视频一区二区三区| 街头女战士在线观看网站| 亚洲情色 制服丝袜| 国产亚洲一区二区精品| 久久鲁丝午夜福利片| 久久久久久伊人网av| 一级毛片我不卡| 成人综合一区亚洲| 国产精品无大码| www.熟女人妻精品国产 | 这个男人来自地球电影免费观看 | 看免费成人av毛片| 99香蕉大伊视频| 精品卡一卡二卡四卡免费| 晚上一个人看的免费电影| 黑丝袜美女国产一区| 色吧在线观看| 丝袜脚勾引网站| 国产深夜福利视频在线观看| 90打野战视频偷拍视频| 七月丁香在线播放| 国产精品熟女久久久久浪| 80岁老熟妇乱子伦牲交| 久久国产精品大桥未久av| 亚洲精品日韩在线中文字幕| 精品一区在线观看国产| 五月天丁香电影| 亚洲精品久久成人aⅴ小说| 国产精品成人在线| 2018国产大陆天天弄谢| 日日爽夜夜爽网站| 亚洲国产成人一精品久久久| 欧美老熟妇乱子伦牲交| 亚洲av中文av极速乱| 精品午夜福利在线看| 色视频在线一区二区三区| 麻豆乱淫一区二区| h视频一区二区三区| 制服丝袜香蕉在线| 91久久精品国产一区二区三区| 国产精品久久久久久精品电影小说| 国产av一区二区精品久久| 精品人妻偷拍中文字幕| 国产激情久久老熟女| 狂野欧美激情性xxxx在线观看| 国产黄色免费在线视频| 亚洲国产精品专区欧美| 黄色毛片三级朝国网站| 高清欧美精品videossex| 亚洲精品美女久久久久99蜜臀 | 少妇人妻久久综合中文| av天堂久久9| 热99国产精品久久久久久7| 日本欧美视频一区| 免费观看av网站的网址| 国产欧美另类精品又又久久亚洲欧美| 国产老妇伦熟女老妇高清| 男人添女人高潮全过程视频| 午夜福利网站1000一区二区三区| 欧美少妇被猛烈插入视频| 18禁动态无遮挡网站| 日本免费在线观看一区| 欧美精品国产亚洲| 男人爽女人下面视频在线观看| 久久久久久久亚洲中文字幕| 最近最新中文字幕大全免费视频 | av不卡在线播放| 国产又色又爽无遮挡免| 欧美bdsm另类| 我要看黄色一级片免费的| 国产精品人妻久久久久久| 亚洲欧美成人综合另类久久久| 国产精品熟女久久久久浪| 18禁国产床啪视频网站| 日本wwww免费看| 午夜激情av网站| www.av在线官网国产| 五月玫瑰六月丁香| 蜜桃国产av成人99| 九九在线视频观看精品| 男女高潮啪啪啪动态图| 成年av动漫网址| 国产女主播在线喷水免费视频网站| 久久热在线av| 欧美精品高潮呻吟av久久| 男人操女人黄网站| 女性被躁到高潮视频| 成年人免费黄色播放视频| 亚洲国产欧美在线一区| 亚洲精品第二区| 精品福利永久在线观看| 最近2019中文字幕mv第一页| 亚洲精品自拍成人| 在线免费观看不下载黄p国产| 国产免费一级a男人的天堂| 国产在视频线精品| 国产精品久久久久久久电影| 中文字幕精品免费在线观看视频 | 九色亚洲精品在线播放| 一级片免费观看大全| 曰老女人黄片| 日韩人妻精品一区2区三区| 国产精品久久久久久精品电影小说| 成年美女黄网站色视频大全免费| 欧美 亚洲 国产 日韩一| 国产有黄有色有爽视频| 午夜91福利影院| 人人妻人人澡人人爽人人夜夜| 亚洲 欧美一区二区三区| 免费在线观看完整版高清| 久久久久人妻精品一区果冻| 色5月婷婷丁香| 久久影院123| 亚洲精品一二三| 成人影院久久| 日韩成人伦理影院| 黑人欧美特级aaaaaa片| 欧美人与善性xxx| 久久人人爽av亚洲精品天堂| 国产在线视频一区二区| 啦啦啦视频在线资源免费观看| 在线天堂中文资源库| 欧美日韩视频高清一区二区三区二| 色5月婷婷丁香| 精品第一国产精品| 91精品三级在线观看| 久久99热这里只频精品6学生| 伦精品一区二区三区| 美女xxoo啪啪120秒动态图| 欧美精品av麻豆av| 欧美人与善性xxx| 日韩成人av中文字幕在线观看| 亚洲成av片中文字幕在线观看 | 春色校园在线视频观看| 精品熟女少妇av免费看| 男人爽女人下面视频在线观看| 天天操日日干夜夜撸| www日本在线高清视频| 狠狠婷婷综合久久久久久88av| 国产在视频线精品| 国产免费一级a男人的天堂| 男人爽女人下面视频在线观看| 永久免费av网站大全| 9热在线视频观看99| 中文天堂在线官网| 欧美成人午夜精品| 哪个播放器可以免费观看大片| 如何舔出高潮| 菩萨蛮人人尽说江南好唐韦庄| 伊人久久国产一区二区| 亚洲成国产人片在线观看| 国产日韩欧美在线精品| 欧美另类一区| 欧美激情国产日韩精品一区| 在线观看免费高清a一片| 精品酒店卫生间| 91精品伊人久久大香线蕉| 久久国产精品大桥未久av| av电影中文网址| 午夜福利在线观看免费完整高清在| 老司机影院成人| 母亲3免费完整高清在线观看 | 内地一区二区视频在线| 我的女老师完整版在线观看| 精品视频人人做人人爽| 伦理电影免费视频| 欧美+日韩+精品| 最近中文字幕高清免费大全6| 欧美激情极品国产一区二区三区 | 亚洲第一区二区三区不卡| 91精品国产国语对白视频| 蜜桃在线观看..| 免费久久久久久久精品成人欧美视频 | 青春草视频在线免费观看| 男人操女人黄网站| 侵犯人妻中文字幕一二三四区| 男女免费视频国产| 午夜福利影视在线免费观看| 日本黄色日本黄色录像| 男女高潮啪啪啪动态图| 亚洲欧美色中文字幕在线| 精品久久久久久电影网| 中文字幕制服av| 亚洲精品视频女| 国产精品嫩草影院av在线观看| 国产精品人妻久久久久久| 国产国拍精品亚洲av在线观看| 乱码一卡2卡4卡精品| av福利片在线| 国产精品国产三级国产专区5o| 久久久久久久久久久久大奶| 一级毛片我不卡| 女人久久www免费人成看片| 综合色丁香网| 国产精品国产av在线观看| 777米奇影视久久| 精品亚洲乱码少妇综合久久| 视频区图区小说| 国产精品久久久久久精品古装| av网站免费在线观看视频| 亚洲精品国产av成人精品| 久久久国产精品麻豆| 综合色丁香网| 日韩在线高清观看一区二区三区| 2018国产大陆天天弄谢| 天天影视国产精品| 99热网站在线观看| 精品99又大又爽又粗少妇毛片| 亚洲美女黄色视频免费看| 下体分泌物呈黄色| 亚洲第一区二区三区不卡| 国产免费一区二区三区四区乱码| 在线天堂中文资源库| 最近中文字幕高清免费大全6| 久久久久久久久久久久大奶| 国产精品免费大片| 又黄又爽又刺激的免费视频.| 99热网站在线观看| 国产深夜福利视频在线观看| 最黄视频免费看| 国产69精品久久久久777片| 亚洲av中文av极速乱| 最近2019中文字幕mv第一页| 伊人亚洲综合成人网| 国产片特级美女逼逼视频| 狠狠婷婷综合久久久久久88av| 热99国产精品久久久久久7| 欧美精品一区二区大全| 欧美亚洲日本最大视频资源| 成人国产av品久久久| av国产久精品久网站免费入址| 男女免费视频国产| 国产日韩欧美视频二区| 亚洲国产av新网站| 两个人免费观看高清视频| 成人漫画全彩无遮挡| 国产成人精品福利久久| 99久国产av精品国产电影| 国产极品天堂在线| 久久久久久人妻| 精品午夜福利在线看| 18禁国产床啪视频网站| 好男人视频免费观看在线| 人成视频在线观看免费观看| 亚洲成人一二三区av| 精品一区二区免费观看| 午夜福利乱码中文字幕| 日日爽夜夜爽网站| 国产女主播在线喷水免费视频网站| 在线观看www视频免费| 免费在线观看黄色视频的| 国产又爽黄色视频| 色视频在线一区二区三区| 国产av码专区亚洲av| 侵犯人妻中文字幕一二三四区| 久久久久精品久久久久真实原创| 日韩制服丝袜自拍偷拍| 国产成人91sexporn| 九九爱精品视频在线观看| 一区二区av电影网| 美女视频免费永久观看网站| 成人手机av| 丰满饥渴人妻一区二区三| 大香蕉久久成人网| 黄网站色视频无遮挡免费观看| 汤姆久久久久久久影院中文字幕| 亚洲精品第二区| 超色免费av| a级毛色黄片| 欧美日韩成人在线一区二区| 久久人人爽人人片av| 男女啪啪激烈高潮av片| 少妇 在线观看| 久久99蜜桃精品久久| 新久久久久国产一级毛片| 欧美另类一区| 成人免费观看视频高清| 日韩 亚洲 欧美在线| 国产国语露脸激情在线看| 美女中出高潮动态图| 校园人妻丝袜中文字幕| 男女免费视频国产| 欧美日韩亚洲高清精品| 亚洲内射少妇av| 国产在线免费精品| a 毛片基地| 91国产中文字幕| 飞空精品影院首页| 久久久久精品久久久久真实原创| 纯流量卡能插随身wifi吗| 极品人妻少妇av视频| 涩涩av久久男人的天堂| 免费不卡的大黄色大毛片视频在线观看| 国产高清三级在线| 久久久国产一区二区| 少妇被粗大的猛进出69影院 | 9热在线视频观看99| 国产片特级美女逼逼视频| 寂寞人妻少妇视频99o| 男人爽女人下面视频在线观看| 日本与韩国留学比较| 老女人水多毛片| 亚洲情色 制服丝袜| 肉色欧美久久久久久久蜜桃| 另类精品久久| 精品午夜福利在线看| 国产一区二区三区综合在线观看 | 视频在线观看一区二区三区| 国产亚洲一区二区精品| 久久精品国产自在天天线| 欧美 日韩 精品 国产| 亚洲美女视频黄频| av在线app专区| 日韩中文字幕视频在线看片| h视频一区二区三区| 国产高清国产精品国产三级| 亚洲久久久国产精品| 啦啦啦视频在线资源免费观看| 夫妻性生交免费视频一级片| 婷婷色综合www| 精品福利永久在线观看| 麻豆精品久久久久久蜜桃| 男人操女人黄网站| 天天影视国产精品| 日日摸夜夜添夜夜爱| 男女啪啪激烈高潮av片| 国产日韩欧美亚洲二区| 观看美女的网站| 永久免费av网站大全| 九九爱精品视频在线观看| av一本久久久久| 国产高清不卡午夜福利| 黄网站色视频无遮挡免费观看| 国产欧美另类精品又又久久亚洲欧美| 久久鲁丝午夜福利片| 亚洲欧美一区二区三区国产| 搡女人真爽免费视频火全软件| 久久久欧美国产精品| 亚洲欧美清纯卡通| 亚洲天堂av无毛| 亚洲丝袜综合中文字幕| 久久午夜福利片| 这个男人来自地球电影免费观看 | 中文乱码字字幕精品一区二区三区| 亚洲一区二区三区欧美精品| 国产精品久久久久久久久免| 国产成人91sexporn| 日韩精品免费视频一区二区三区 | 欧美日韩综合久久久久久| 夫妻午夜视频| 日韩视频在线欧美| 成人影院久久| 久久久国产精品麻豆| 老司机亚洲免费影院| 只有这里有精品99| 精品99又大又爽又粗少妇毛片| 各种免费的搞黄视频| 人妻 亚洲 视频| 国产精品一区二区在线不卡| 亚洲中文av在线| 精品福利永久在线观看| 久久久久久人人人人人| 欧美精品国产亚洲| 国产一区二区三区综合在线观看 | 欧美xxⅹ黑人| a级毛片黄视频| 免费在线观看黄色视频的| 久久精品熟女亚洲av麻豆精品| 免费大片18禁| 狠狠婷婷综合久久久久久88av| 啦啦啦啦在线视频资源| 日日撸夜夜添| 日日啪夜夜爽| 亚洲欧洲精品一区二区精品久久久 | 国产一区二区三区av在线| 一个人免费看片子| 在线观看国产h片|